These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27590169)

  • 1. Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment.
    Lloyd AJ; Gallop K; Ali S; Hughes D; MacCulloch A
    Curr Med Res Opin; 2017 Jan; 33(1):23-29. PubMed ID: 27590169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
    Harrison M; Marra C; Shojania K; Bansback N
    Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective.
    Johnston KM; Audhya IF; Dunne J; Feeny D; Neumann P; Malone DC; Szabo SM; Gooch KL
    Appl Health Econ Health Policy; 2024 May; 22(3):343-352. PubMed ID: 38253973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To explore preferences and willingness to pay for attributes regarding stoma appliances amongst patients in the UK, France and Germany.
    Nafees B; Lloyd A; Elkin E; Porret T
    Curr Med Res Opin; 2015 Apr; 31(4):687-95. PubMed ID: 25651482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.
    Danner M; Vennedey V; Hiligsmann M; Fauser S; Gross C; Stock S
    Value Health; 2017 Sep; 20(8):1166-1173. PubMed ID: 28964450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility Values Associated with Atypical Hemolytic Uremic Syndrome-Related Attributes: A Discrete Choice Experiment in Five Countries.
    Williams K; Aggio D; Chen P; Anokhina K; Lloyd AJ; Wang Y
    Pharmacoeconomics; 2021 Aug; 39(8):901-912. PubMed ID: 34195967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
    de Freitas HM; Ito T; Hadi M; Al-Jassar G; Henry-Szatkowski M; Nafees B; Lloyd AJ
    Adv Ther; 2019 Feb; 36(2):318-332. PubMed ID: 30617763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
    Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
    Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.
    Liu T; Tsang W; Huang F; Lau OY; Chen Y; Sheng J; Guo Y; Akinwunmi B; Zhang CJ; Ming WK
    J Med Internet Res; 2021 Feb; 23(2):e22841. PubMed ID: 33493130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculating Preference Weights for the Labor and Delivery Index: A Discrete Choice Experiment on Women's Birth Experiences.
    Gärtner FR; de Bekker-Grob EW; Stiggelbout AM; Rijnders ME; Freeman LM; Middeldorp JM; Bloemenkamp KW; de Miranda E; van den Akker-van Marle ME
    Value Health; 2015 Sep; 18(6):856-64. PubMed ID: 26409614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A discrete choice experiment to determine UK patient preference for attributes of disease modifying treatments in Multiple Sclerosis.
    Bottomley C; Lloyd A; Bennett G; Adlard N
    J Med Econ; 2017 Aug; 20(8):863-870. PubMed ID: 28562125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries.
    Lo SH; Lawrence C; Martí Y; Café A; Lloyd AJ
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):103-115. PubMed ID: 34897574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.
    Ossa DF; Briggs A; McIntosh E; Cowell W; Littlewood T; Sculpher M
    Pharmacoeconomics; 2007; 25(3):223-37. PubMed ID: 17335308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
    Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
    Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A discrete choice experiment to determine patient preferences for injection devices in multiple sclerosis.
    Shingler SL; Swinburn P; Ali S; Perard R; Lloyd AJ
    J Med Econ; 2013 Aug; 16(8):1036-42. PubMed ID: 23730944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
    Mühlbacher A; Bethge S
    Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.
    Gelhorn HL; Stringer SM; Brooks A; Thompson C; Monz BU; Boye KS; Hach T; Lund SS; Palencia R
    Diabetes Obes Metab; 2013 Sep; 15(9):802-9. PubMed ID: 23464623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment.
    Si L; Tu L; Xie Y; Palmer AJ; Gu Y; Zheng X; Li J; Lv Q; Qi J; Lin Z; Chen M; Gu J; Hiligsmann M
    Arch Osteoporos; 2019 Jul; 14(1):85. PubMed ID: 31367860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences for chronic lymphocytic leukemia treatments: a discrete-choice experiment.
    Ravelo A; Myers K; Brumble R; Bussberg C; Koffman B; Manzoor BS; Biondo JML; Mansfield C
    Future Oncol; 2024; 20(28):2059-2070. PubMed ID: 38861284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.